• VRight AARYANA posted an update in the group Retail Investor Forum

    3 months, 3 weeks ago

    Stocks recommendations -July 16, 2025

    Retail & Lifestyle

    Vishal Mega Mart (MOSL – Buy, TP ₹165)
    • A unique retail play on Tier 2+ India’s rising aspirations.
    • Operates in a ₹70T+ opportunity with 73% revenues from private labels.
    • Focused on value retail across apparel (44%), GM (28%), and FMCG (28%).
    • Double-digit growth across revenue/EBITDA/PAT: 19%/20%/24% CAGR expected.
    Trend and Relevance: High-growth, rural value retail leader with lean cost structure.

    Aditya Birla Lifestyle (Bernstein – Market Perform, TP ₹170)
    • Brand-led business resetting its growth agenda.
    • Lifestyle category is saturated, but emerging brands offer tailwinds.
    • Expected growth: ~9.5% CAGR FY25–30.
    Trend and Relevance: Limited upside due to segment saturation; needs strong execution.

    Manufacturing & Electronics

    Dixon Technologies
    • CLSA: High Conviction Outperform, TP ₹19,000
    • Nomura: Buy, TP ₹21,409
    • JPMorgan: Overweight, TP ₹17,700
    Key Triggers:
    • Foray into camera modules & precision components via JV with Q Tech.
    • Value addition in smartphones to rise to 45–55% from current 15–17%.
    • Backward integration to improve margins by 150–200bps; EPS upside of 2–5%.
    Trend and Relevance: Structural margin expansion and EPS upgrades through JVs and vertical integration.

    Insurance & Financials

    HDFC Life
    • Citi: Buy, TP ₹975 | HSBC: Buy, TP ₹900 | MS: Overweight, TP ₹840
    • Macquarie: Underperform, TP ₹720 | MOSL: Buy, TP ₹7,910 | Nuvama: Buy, TP ₹7,920
    Takeaways:
    • VNB margin stable at ~25%; APE growth supported by ULIP and PAR.
    • Business is agile with deepening distribution, but valuations seen as rich (Macquarie).
    • MOSL/Nuvama trim FY26–27 margin estimates by 50 bps post Q1.
    Trend and Relevance: Mixed sentiment. While core strength remains, margin trajectory is a key watch.

    ICICI Prudential Life
    • Citi: Buy, TP ₹850 | MOSL: Buy, TP ₹780 | Nuvama: Buy, TP ₹770
    Highlights:
    • Strong performance in non-linked savings & protection.
    • Margins up at 24.5%; VNB guidance revised upward.
    • Re-rating potential due to improving persistency and mix.
    Trend and Relevance: Strong margin profile and product mix support positive view.

    ICICI Lombard
    • Macquarie: Outperform, TP ₹2,255
    • MS: Equal Weight, TP ₹1,885
    • MOSL: Buy, TP ₹2,400
    • Nuvama: Buy, TP ₹2,340
    Summary:
    • Q1 PAT beat estimates due to investment income.
    • Combined ratio a bit weak, but stable trends expected going forward.
    • Premium growth expected to revive with better motor segment traction.
    Trend and Relevance: Healthy margin outlook; competition in motor and health remains a risk.

    Pharmaceuticals & Biotech

    Biocon (MOSL – Positive)
    • USFDA approval for Kirsty — the first interchangeable biosimilar to Insulin Aspart (Novolog, $1.2B sales).
    • Competitor landscape still emerging; capacity constraints at Novo may benefit Biocon.
    Trend and Relevance: Major regulatory milestone with large market potential.

    Sun Pharma
    • Settled US litigation with Incyte; launching Leqselvi in the US for alopecia areata.
    Trend and Relevance: Expands non-oncology portfolio; enhances US revenue pipeline.

    Agrochemicals
    Rallis India (HSBC – Reduce, TP ₹250)
    • 1Q beat estimates; volume-led growth and better margin from cost optimization.
    • Structural improvement likely gradual; valuation stretched.
    Trend and Relevance: Improving operations, but near-term upside limited.

    FMCG & Agri
    AWL Agri (JPMorgan – Underweight, TP ₹260)
    • Weak quarter; muted palm oil volumes dragged edible oils.
    • Food & FMCG segment focus is on reviving revenue, even if margins moderate.
    Trend and Relevance: Margin pressure + demand headwinds = cautious outlook.

    Auto & EV
    Tesla India Launch – Sector Commentary
    • Bernstein: Focused on brand, not volumes yet; limited near-term risk to local OEMs.
    • Macquarie: M&M, Tata not under threat due to Tesla’s premium pricing.
    • Citi: No overlap with Mahindra EV customer base. Watch if tariffs drop or local manufacturing begins.
    Trend and Relevance: Tesla presence is not a near-term threat, but watch policy/duty changes.

    Banks
    HDFC Bank (Macquarie – Outperform, TP ₹2,400)
    • Q1 weak for subsidiary HDB; margin expansion of 10bps helped offset some weakness.
    Trend and Relevance: Near-term vehicle finance sluggish; longer-term outlook stable.

    Real Estate
    Oberoi Realty (MS – Equal-weight, TP ₹1,700)
    • Acquisition of Versova land; low impact on NAV. Gross margin ~55%.
    • Launch likely in FY28; long-dated value unlocking.
    Trend and Relevance: Strong pipeline; execution is medium to long-term.

    Technology & Platforms

    Just Dial (Citi – Buy, TP ₹1,100)
    • Revenue growth slowed to 6% YoY; traffic grew just 7%.
    • CMP at <8x Mar’27E PE (ex-cash); strong balance sheet.
    Trend and Relevance: Valuation comfort + upside from potential cash deployment.

    Status Image